CMS is adding Elsevier Gold Standard's Clinical Pharmacology to the list of authoritative compendia it recognizes for determining off-label coverage of cancer drugs under Medicare Part B, the agency announced July 2. The decision is part of the agency's efforts to update the reference guides used by Medicare carriers in making reimbursement decisions ("The Pink Sheet" DAILY, April 18, 2008). Under a newly developed process, CMS will annually accept stakeholder requests for updates to the list. Clinical...